Selection of influenza vaccine strains and developing pandemic vaccines. (Q30332305)

18 June 2017

1 reference

title

Selection of influenza vaccine strains and developing pandemic vaccines. (English)

1 reference

18 June 2017

0 references

1 reference

Wood JM

1 reference

18 June 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

18 June 2017

1 reference

18 June 2017

volume

20 Suppl 5

1 reference

18 June 2017

page(s)

B40-4

1 reference

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

18 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

Swine Influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and Speculation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

Summary of Clinical Trials of Inactivated Influenza Vaccine--1978

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900509-1

7 January 2021

10.1016/S0264-410X(02)00509-1

Identifiers

DOI

1 reference

18 June 2017

1 reference